{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Rasquinha MT"],"funding":["American Heart Association","Jackson Laboratory's Diversity Outbred Pilot Grant Program"],"pagination":["266"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10975958"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(3)"],"pubmed_abstract":["Group B coxsackieviruses (CVBs) cause a wide range of diseases in humans, but no vaccines are currently available to prevent these infections. Previously, we had demonstrated that a live attenuated CVB3 vaccine virus, Mutant 10 (Mt10), offers protection against multiple CVB serotypes as evaluated in various inbred mouse strains; however, the applicability of these findings to the outbred human population remains uncertain. To address this issue, we used Diversity Outbred (DO) mice, whose genome is derived from eight inbred mouse strains that may capture the level of genetic diversity of the outbred human population. To determine the efficacy of the Mt10 vaccine, we established the CVB3 infection model in the DO mice. We noted that CVB3 infection resulted mainly in pancreatitis, although vi"],"journal":["Vaccines"],"pubmed_title":["Mt10 Vaccine Protects Diversity Outbred Mice from CVB3 Infection by Producing Virus-Specific Neutralizing Antibodies and Diverse Antibody Isotypes."],"pmcid":["PMC10975958"],"funding_grant_id":["18TPA34170206","x"],"pubmed_authors":["Mone K","Rasquinha MT","Sur M","Massilamany C","Lasrado N","Reddy J","Steffen D","Kachman SD"],"additional_accession":[]},"is_claimable":false,"name":"Mt10 Vaccine Protects Diversity Outbred Mice from CVB3 Infection by Producing Virus-Specific Neutralizing Antibodies and Diverse Antibody Isotypes.","description":"Group B coxsackieviruses (CVBs) cause a wide range of diseases in humans, but no vaccines are currently available to prevent these infections. Previously, we had demonstrated that a live attenuated CVB3 vaccine virus, Mutant 10 (Mt10), offers protection against multiple CVB serotypes as evaluated in various inbred mouse strains; however, the applicability of these findings to the outbred human population remains uncertain. To address this issue, we used Diversity Outbred (DO) mice, whose genome is derived from eight inbred mouse strains that may capture the level of genetic diversity of the outbred human population. To determine the efficacy of the Mt10 vaccine, we established the CVB3 infection model in the DO mice. We noted that CVB3 infection resulted mainly in pancreatitis, although vi","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2025-04-26T11:20:36.209Z","creation":"2025-04-06T13:41:20.289Z"},"accession":"S-EPMC10975958","cross_references":{"pubmed":["38543901"],"doi":["10.3390/vaccines12030266"]}}